STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2167 by analyst upside · 2026-06-27
MMSI
Merit Medical Systems, Inc.
Healthcare · Market Cap $4B · P/E 30.9x
ANALYST PRICE TARGET
+24.8%
implied upside to consensus target
Current Price $71.73
Consensus Target $89.55
Bull Target $110.0
Bear Target $74.0
Analysts Covering 11
ANALYST CONSENSUS - BUY
Strong Buy
5
Buy
4
Hold
2
Sell
0
52-Week Low $59.74
52-Week High $96.74
YTD Return -17.0%
FUNDAMENTALS
Market Cap $4B
P/E Ratio (TTM) 30.9x
Forward P/E 16.3x
EPS (TTM) $2.32
PEG Ratio 1.46
Dividend Yield N/A
Revenue (TTM) $1.5B
Profit Margin 9.0%
52-WEEK RANGE
52-Week Low $59.74
52-Week High $96.74
Current Price $71.73
Bear Target $74.0
Bull Target $110.0
● Now $71.73 ● Target $89.55
TRADING DATA
Avg Volume 763K
YTD Return -17.0%
Analyst Count 11
Consensus Buy
Upside to Target +24.8%
Last Updated 2026-06-27

ANALYST SUMMARY

Merit Medical Systems, Inc. (MMSI) is currently trading at $71.73 with a Wall Street consensus price target of $89.55, implying potential upside of 24.8% over the next 12 months. 11 analysts currently cover MMSI, with a consensus rating of Buy - 82% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $110.0, while the most cautious has a target of $74.0.

MMSI operates in the Healthcare sector with a market capitalisation of $4B. The stock is down 17.0% year-to-date and is currently trading near the lower end of its 52-week range of $59.74 – $96.74.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MMSI, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity — Reiterated
Buy → Buy 2026-05-01 Building track record
JP Morgan — Reiterated
Overweight → Overweight 2026-05-01 43% win rate (7 calls)
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-05-01 Building track record
Needham — Reiterated
Buy → Buy 2026-05-01 20% win rate (5 calls)
Barrington Research — Reiterated
Outperform → Outperform 2026-04-20 Building track record
Piper Sandler — Reiterated
Overweight → Overweight 2026-04-17 14% win rate (7 calls)
Canaccord Genuity — Reiterated
Buy → Buy 2026-04-07 Building track record
Needham reit
Buy → Buy 2026-04-01 20% win rate (5 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
61
out of 100
Coverage depth
19/30
Consensus clarity
20/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →